v3 Template
V

Valink Therapeutics Inc.

Biotechnology / Healthcare ~560 employees
Founded
--
Employees (Est.)
~560
28 leaders known
Total Funding
$11.8M
Funding Rounds
1
Last Funding
2025-10-20

About Valink Therapeutics Inc.

Valink Therapeutics is a biotechnology company focused on developing novel therapeutics, specifically next-generation bispecific antibody-drug conjugates (ADCs), to more effectively attack tumors while sparing healthy tissue. Their mission is to build drugs that minimize side effects, enable new payloads, and cure more people by differentiating disease from healthy cells.

Products & Services

Bispecific Antibody-Drug Conjugates (ADCs):Next-generation ADCs designed to be more potent against tumors using innovative gating approaches like AND-GATE, OR-GATE, and V-GATE, which tune the drug's response to molecular targets on cancer cells.
LiliumX™ Platform:A proprietary discovery engine based on synthetic protein biology, high-throughput functional screening, and AI, used to explore and identify potential bispecific ADC drugs.
Oncology Pipeline:Includes programs such as VLN1, VLN2, VLN3, and VLN4 targeting indications like CRC, NSCLC, GYN, solid tumors, and pan-cancer, currently in discovery and lead optimization/preclinical stages.

Specialties

Bispecific Antibody-Drug Conjugates (ADCs) Oncology Synthetic Protein Biology High-Throughput Functional Screening Artificial Intelligence (AI) in Drug Discovery V-Gate Technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Pre-A
T: -
FT: Pre-A
A: 11800000
MR: -
FA: 11.8 million
FAN: 11800000
D: 2025-10-20
FD: 2025-10-20
6 investors
Pre-A Latest
2025-10-20
$11.8M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Arne Scheu

CEO & Director

LinkedIn (Pro only)
I

Irsyad Khairil

CTO & Director

LinkedIn (Pro only)
J

Jose Munoz-Olaya

CSO

LinkedIn (Pro only)
N

Nikitas Georgakopoulos

Principal Scientist

B

Ben Dorgan

Senior Scientist II

I

Inês Sá Pereira

Senior Scientist I

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

Valink Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~560 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro